| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 505363
[patent_doc_number] => 07202227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Multifunctional molecular complexes for gene transfer to cells'
[patent_app_type] => utility
[patent_app_number] => 10/010114
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31883
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010114 | Multifunctional molecular complexes for gene transfer to cells | Nov 12, 2001 | Issued |
Array
(
[id] => 7013976
[patent_doc_number] => 20050066379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Preparing somatic embryo by utilizing rabbit oocyte'
[patent_app_type] => utility
[patent_app_number] => 10/494075
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5183
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20050066379.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494075 | Preparing somatic embryo by utilizing rabbit oocyte | Nov 5, 2001 | Abandoned |
Array
(
[id] => 310951
[patent_doc_number] => 07527974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-05
[patent_title] => 'Embryonic stem cells derived from human somatic cell—rabbit oocyte NT units'
[patent_app_type] => utility
[patent_app_number] => 10/494074
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 17
[patent_no_of_words] => 9391
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/527/07527974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494074 | Embryonic stem cells derived from human somatic cell—rabbit oocyte NT units | Nov 5, 2001 | Issued |
Array
(
[id] => 1240377
[patent_doc_number] => RE038392
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2004-01-20
[patent_title] => 'Method for identifying metastatic sequences'
[patent_app_type] => E1
[patent_app_number] => 09/985799
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 71
[patent_no_of_words] => 26380
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038392.pdf
[firstpage_image] =>[orig_patent_app_number] => 09985799
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/985799 | Method for identifying metastatic sequences | Nov 5, 2001 | Issued |
Array
(
[id] => 1174856
[patent_doc_number] => 06750375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-15
[patent_title] => 'Transgenic mouse comprising a disruption in an RGS9 gene'
[patent_app_type] => B2
[patent_app_number] => 09/999746
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 8717
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750375.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999746
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999746 | Transgenic mouse comprising a disruption in an RGS9 gene | Oct 22, 2001 | Issued |
Array
(
[id] => 1202126
[patent_doc_number] => RE038490
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2004-04-06
[patent_title] => 'Method for identifying metastatic sequences'
[patent_app_type] => E1
[patent_app_number] => 09/977371
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 71
[patent_no_of_words] => 26385
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09977371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/977371 | Method for identifying metastatic sequences | Oct 15, 2001 | Issued |
Array
(
[id] => 6636771
[patent_doc_number] => 20020086847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 09/975932
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15213
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086847.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975932
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975932 | Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof | Oct 14, 2001 | Abandoned |
Array
(
[id] => 6813684
[patent_doc_number] => 20030073234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Clonal human embryonic stem cell lines and methods of generating same'
[patent_app_type] => new
[patent_app_number] => 09/975011
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7249
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073234.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975011
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975011 | Clonal human embryonic stem cell lines and methods of generating same | Oct 11, 2001 | Abandoned |
Array
(
[id] => 760004
[patent_doc_number] => 07011828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-14
[patent_title] => 'Implanting neural progenitor cells derived for human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 09/970543
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 27378
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/011/07011828.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970543
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970543 | Implanting neural progenitor cells derived for human embryonic stem cells | Oct 3, 2001 | Issued |
Array
(
[id] => 1309841
[patent_doc_number] => 06610290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-26
[patent_title] => 'Adeno associated virus vectors for the treatment of a cardiomyopathy'
[patent_app_type] => B2
[patent_app_number] => 09/969204
[patent_app_country] => US
[patent_app_date] => 2001-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16074
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610290.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969204
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969204 | Adeno associated virus vectors for the treatment of a cardiomyopathy | Sep 30, 2001 | Issued |
| 09/969327 | Methods of treating anemia using recombinant adeno-associated virus virions | Sep 30, 2001 | Abandoned |
| 09/856689 | Cryopreservation of oocytes and embryos and methods for producing animals involving the same | Sep 25, 2001 | Abandoned |
Array
(
[id] => 5935934
[patent_doc_number] => 20020061515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Model for neurodegenerative diseases involving amyloid accumulation'
[patent_app_type] => new
[patent_app_number] => 09/961381
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22497
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061515.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961381
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961381 | Determining the effect of a substance on sequestration, uptake, and accumulation of amyloid in brain cells | Sep 24, 2001 | Issued |
Array
(
[id] => 6847104
[patent_doc_number] => 20030166271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Method for growing stem cells'
[patent_app_type] => new
[patent_app_number] => 09/957458
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 7542
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166271.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957458
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957458 | Method for growing stem cells | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6283647
[patent_doc_number] => 20020108131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'SR-BI and apo E knockout animals and use thereof as models for atherosclerosis and heart attack'
[patent_app_type] => new
[patent_app_number] => 09/951936
[patent_app_country] => US
[patent_app_date] => 2001-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13200
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20020108131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09951936
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/951936 | SR-BI and apo E knockout animals and use thereof as models for atherosclerosis and heart attack | Sep 12, 2001 | Abandoned |
Array
(
[id] => 6131389
[patent_doc_number] => 20020077311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Genetically-engineered myoblasts and cardiac myocytes as drug delivery systems'
[patent_app_type] => new
[patent_app_number] => 09/953033
[patent_app_country] => US
[patent_app_date] => 2001-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5920
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077311.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953033
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953033 | Genetically-engineered myoblasts and cardiac myocytes as drug delivery systems | Sep 12, 2001 | Abandoned |
Array
(
[id] => 769310
[patent_doc_number] => 07005424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-28
[patent_title] => 'Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 09/943984
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 84
[patent_no_of_words] => 46631
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005424.pdf
[firstpage_image] =>[orig_patent_app_number] => 09943984
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/943984 | Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy | Aug 30, 2001 | Issued |
Array
(
[id] => 6603203
[patent_doc_number] => 20020015694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Hematopoietic differentiation of human embryonic stem cells'
[patent_app_type] => new
[patent_app_number] => 09/940175
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20020015694.pdf
[firstpage_image] =>[orig_patent_app_number] => 09940175
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/940175 | Hematopoietic differentiation of human embryonic stem cells | Aug 26, 2001 | Issued |
Array
(
[id] => 6554045
[patent_doc_number] => 20020164304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Adenovirus-mediated transfer of genes to the lung'
[patent_app_type] => new
[patent_app_number] => 09/935423
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10119
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20020164304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935423 | Adenovirus-mediated transfer of genes to the lung | Aug 22, 2001 | Abandoned |
Array
(
[id] => 6016923
[patent_doc_number] => 20020103153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Inhibition of cellular proliferation by oligonucleotide binding to a chromosomal binding site for p53 protein'
[patent_app_type] => new
[patent_app_number] => 09/935247
[patent_app_country] => US
[patent_app_date] => 2001-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7471
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103153.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935247
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935247 | Inhibition of cellular proliferation by oligonucleotide binding to a chromosomal binding site for p53 protein | Aug 21, 2001 | Issued |